Professional overview
Associate Chief Physician and Master's Supervisor in the Department of Urology at Renji Hospital, specializing in urologic oncology, with deep expertise in bladder cancer.
SpecialtyUrology
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Urology
HospitalRenji Hospital
CityShanghai
Hospital roleExecutive Director, Department of Urology, Hangzhou Bay Campus, Renji Hospital
CampusWest Campus
Areas of focus
Bladder cancerDeveloped a multimodal bladder-preserving treatment strategy for high-risk non-muscle-invasive and muscle-invasive bladder cancer, integrating precise patient selection, trimodality therapy (TMT), and immunotherapy combinations.
Minimally invasive surgeryPerforms robot-assisted and laparoscopic radical cystectomy independently, and has extensive experience in complex urinary diversion procedures.
Variant histology bladder cancerManages rare and aggressive bladder cancer subtypes including adenocarcinoma, squamous cell carcinoma, micropapillary carcinoma, small cell carcinoma, sarcomatoid carcinoma, and serous carcinoma.
Background
- 2018Began postdoctoral research in urologic oncology at The University of Texas MD Anderson Cancer Center
- 2020Completed postdoctoral research at The University of Texas MD Anderson Cancer Center
Experience & recognition
- Principal investigator of 2 National Natural Science Foundation of China (NSFC) grants, 1 Shanghai Municipal Science and Technology Commission grant, and 1 Shanghai Municipal Health Commission grant
- Holds 1 invention patent and 2 utility model patents
- Published over 20 SCI papers in journals including Nature Communications, Journal of Hematology & Oncology, Frontiers in Immunology, Journal of Pathology, European Urology Oncology, iScience, and International Journal of Cancer
- Invited speaker at the American Urological Association (AUA) Annual Meeting, European Association of Urology (EAU) Annual Congress, and Société Internationale d'Urologie (SIU) World Congress
- Awarded the Second Prize of Shanghai Science and Technology Progress Award (2014) and the First Prize of Ministry of Education Science and Technology Progress Award (2015) as a core contributor
Professional roles
- Reviewer, Urologic Oncology
- Reviewer, World Journal of Urology
Frequently asked questions
What does Dr. Yang Guoliang specialize in?
Specializes in urologic oncology, especially bladder cancer — including minimally invasive radical cystectomy, multimodal bladder-preserving treatment for high-risk and muscle-invasive disease, and management of variant histology subtypes such as micropapillary, small cell, and sarcomatoid carcinomas.
Which hospital and department is Dr. Yang Guoliang in?
Department of Urology at Renji Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Yang Guoliang has not reviewed this page.
